Products

What will AGI do for Benzthiazide?

This classification denotes a thiazide diuretic with the molecular formula C15H14ClN3O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1TD8J48L61, chemically known as 6-chloro-7-sulfamoyl-3-benzylthiomethyl-2h-1,2,4-benzothiadiazine 1,1-dioxide but generally known as benzthiazide, which bears US NIH Compound Identifier 2343. European Medicines Agency schedules Benzthiazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05769MIG. The term BENZTHIAZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). BENZTHIAZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzthiazide under HS 29350090 and SITC 51580. As of Q4 2014, BENZTHIAZIDE remains the US FDA Preferred Term for this commodity. Benzthiazide bears US NLM identifiers UMLS ID C0053245 and NCI Concept Code C65254. SMILES: CLC1C(S(=O)(=O)N)CC2S(=O)(=O)N=C(NC2C1)CSCC1CCCCC1.

How AGI delivers it

Four ways AGI delivers for Benzthiazide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Benzthiazide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Benzthiazide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Benzthiazide connects

measured by

  • Active Ingredient Assaymodel
  • Assay Puritymodel
  • Content Uniformitymodel
  • Impurity Contentmodel
  • Loss On Dryingmodel
  • Tablet Dissolution Ratemodel